Piramal Pharma Solutions Unlocks FDA-Approved Analytical Capabilities

• Piramal Pharma Solutions’ Ahmedabad facility successfully completed an FDA inspection, unlocking advanced analytical capabilities.

• The facility now offers FDA-approved services including method development, product characterization, and analytical validation.

Piramal Pharma Solutions has announced the successful completion of an FDA inspection at its PPDS Ahmedabad facility. This achievement unlocks access to advanced FDA-approved analytical capabilities for the company’s customers. The services now available include method development, product characterization, analytical investigation, analytical validation, product testing, and product stability housing and testing.

The Ahmedabad facility also offers unique analytical solutions in XRPD, Nitrosamine, Elemental impurities, and Extractable-Leachable analysis. This milestone reflects the company’s commitment to maintaining high standards of compliance and quality.

A spokesperson from Piramal Pharma Solutions commented, “This milestone wouldn’t have been possible without the dedication and hard work of our incredible colleagues and the unwavering support of our valued customers.”